We are Ethyl(triphenyl)phosphonium bromide CAS:1530-32-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name:Ethyl(triphenyl)phosphonium bromide
CAS.NO:1530-32-1
Synonyms:Ethyl(triphenyl)phosphonium bromide
Ethyltriphenylphosphonium bromide
ethyltriphenyl phosphonium bromide
triphenylethylphosphonium bromide
Ethyl triphenyl phosphonium bromide
Physical and Chemical Properties:
Melting Point 203-205 °C(lit.)
Molecular Formula C20H20BrP
Molecular Weight 371.251
Flash Point 200 °C
Exact Mass 370.048584
PSA 13.59000
LogP 1.00440
Water Solubility 120 g/L (23 ºC)
Specification:
Appearance:White to off-white crystalline powder
Assay:99%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Phase-transfer catalyst in chemical reactions.
Our quaternary ammonium salt series products reach more than 200 kinds, and the product categories cover high-content quaternary ammonium salt (powder, crystal, paste), low-content quaternary ammonium salt (liquid, paste), special quaternary ammonium salt, and quaternary ammonium salt. Alkali, etc., and can provide customized services for related products.
Our main R&D directions are: oilfield chemicals and quaternary ammonium salt downstream products (such as emulsifiers for pesticides, disinfectants for aquatic products, surfactants with special requirements for daily chemicals, etc.) and new innovative structures Surfactant. Therefore, in addition to supplying conventional surfactant products, we can also customize various surfactant products with special requirements according to customer needs to meet the special needs of various industries for surfactants.
Market News:Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. 5-bromo-2-methyl-1,3-thiazole-4-carboxylic acid manufacturer.The most frequently reported adverse events for anifrolumab in the TULIP-1 and TULIP-2 trials were upper respiratory tract infection, bronchitis, infusion-related reactions and herpes zoster. 2-{Ethyl[3-({4-[(3-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyra zol-5-yl)amino]-7-quinazolinyl}oxy)propyl]amino}ethyl dihydrogen phosphate (2E)-2-butenedioate (1:1) supplier.In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. ethyl 2-(2-methoxyphenyl)-1,3-thiazole-4-carboxylate producer.
